All Online

1 - 10 of 10 results

Refine

Active filters

Gastroenterology & Hepatology
1 CME CREDIT

In this session Dr. Chopra, a world renowned hepatologist, thinker, inspirational speaker and bestselling author will simulate commonly posed curbside and email questions to a hepatologist from a primary care clinician. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 9, 2020, and they are subject to change as new information is published.


1 CME CREDIT

USPSTF Updates 2020-2021: What PCPs Need to Know

1.00 CME/MOC
1.00 AANP | 0.25 Pharmacology

Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Hear about important changes regarding which patients should be screened for colorectal cancer, lung cancer, and hepatitis C virus infection. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.


0.75 CME CREDIT

Top COVID-19 Questions: Mental Health and Gastroenterology

0.75 CME/MOC
0.75 AANP | 0.25 Pharmacology

The COVID-19 pandemic has taken its toll not only on patients’ lungs but on their gastrointestinal systems and mental health as well. Drs. Shirah Vollmer and Neilanjan Nandi share practical answers to the top questions they frequently hear from other clinicians on COVID-19−related GI and anxiety disorders. Chances are, you have some of the same questions! Get the answers you need to steer your patients through this difficult time.


1 CME CREDIT

Advanced GI dietitian Bethany Doerfler and GI Health Psychologist Sarah Quinton guide you through nutrition and lifestyle trends related to food intolerances, food allergies and GI health in 2020. Critical differences exist between food intolerances and IgE food allergies or Celiac disease. Consumers are often overwhelmed but interested in the role of dietary manipulation on GI health. This talk will focus on data surrounding the accuracy of testing, recommended diet and lifestyle therapy, and the impact of diet on eating behaviors and quality of life. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/14/2020, and they are subject to change as new information is published.


Close up of man holding his knee in pain
1 CME CREDIT

Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.


0.25 CME CREDIT

Cutting Through the Fog: Recognizing Gluten-Induced Neurocognitive Impairment - Frankly Speaking EP 242

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects.


0.25 CME CREDIT

The degree to which early exposure to gluten-containing foods affects the risk of developing celiac disease is controversial. Join us as we discuss a recent Norwegian study suggesting that the timing of introduction of gluten in the diet may be less important than the amount of gluten in the diet at 18 months of age.


0.25 CME CREDIT

Heartburn - Why "Test and Treat" Is Best - Frankly Speaking EP 157

Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato

0.25 CME

Heartburn is a frequent complaint in primary care practices. The etiology is broad, from reflux to H. pylori infection and PUD. While many clinicians treat symptomatically, this may not lead to patient satisfaction. A recent network meta-analysis published in The BMJ, concluded that a ‘test and treat’ approach resulted in the lowest reports for patients to remain symptomatic at follow-up.